GeoVax Backs Bipartisan Initiative to Onshore Vaccine Manufacturing
GeoVax supports bipartisan effort to bring vaccine manufacturing back to the U.S., emphasizing the significance of national health security and pandemic preparedness. The company's MVA platform is at the forefront of advancing multi-antigen vaccines for high-risk populations.
This news highlights the importance of rebuilding U.S.-based vaccine manufacturing to enhance national security and protect vulnerable populations. It underscores the critical role of domestic vaccine production in ensuring resilience during health crises.
